Bank of New York Mellon’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $123K | Buy |
|
|||||
2024
Q4 | $113K | Buy |
|
|||||
2024
Q3 | $354K | Sell |
|
|||||
2024
Q2 | $661K | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $66.9K | Hold |
|
|||||
2023
Q3 | $51K | Sell |
|
|||||
2023
Q2 | $59.3K | Sell |
|
|||||
2023
Q1 | $717K | Sell |
|
|||||
2022
Q4 | $1.39M | Buy |
|
|||||
2022
Q3 | $1.54M | Buy |
|
|||||
2022
Q2 | $1.25M | Sell |
|
|||||
2022
Q1 | $2.8M | Sell |
|
|||||
2021
Q4 | $3.91M | Sell |
|
|||||
2021
Q3 | $6.19M | Sell |
|
|||||
2021
Q2 | $8.52M | Buy |
|
|||||
2021
Q1 | $6.64M | Buy |
|
|||||
2020
Q4 | $5.71M | Buy |
|
|||||
2020
Q3 | $7.11M | Buy |
|
|||||
2020
Q2 | $16.3M | Buy |
|
|||||
2020
Q1 | $2.51M | Buy |
|
|||||
2019
Q4 | $988K | Sell |
|
|||||
2019
Q3 | $767K | Sell |
|
|||||
2019
Q2 | $1.14M | Buy |
|
|||||
2019
Q1 | $1.39M | Buy |
|
|||||
2018
Q4 | $1.44M | Buy |
|
|||||
2018
Q3 | $1.93M | Buy |
|
|||||
2018
Q2 | $1.33M | Sell |
|
|||||
2018
Q1 | $1.75M | Buy |
|
|||||
2017
Q4 | $1.47M | Sell |
|
|||||
2017
Q3 | $2.42M | Buy |
|
|||||
2017
Q2 | $2.55M | Sell |
|
|||||
2017
Q1 | $2.27M | Buy |
|
|||||
2016
Q4 | $2.29M | Buy |
|
|||||
2016
Q3 | $2.98M | Sell |
|
|||||
2016
Q2 | $3.14M | Sell |
|
|||||
2016
Q1 | $2.98M | Buy |
|
|||||
2015
Q4 | $2.21M | Sell |
|
|||||
2015
Q3 | $2.07M | Sell |
|
|||||
2015
Q2 | $3.52M | Buy |
|
|||||
2015
Q1 | $2.56M | Sell |
|
|||||
2014
Q4 | $2.91M | Buy |
|
|||||
2014
Q3 | $2.69M | Buy |
|
|||||
2014
Q2 | $2.86M | Buy |
|
|||||
2014
Q1 | $803K | Buy |
|
|||||
2013
Q4 | $640K | Sell |
|
|||||
2013
Q3 | $610K | Buy |
|
|||||
2013
Q2 | $43K | Buy |
|